Igene Biotechnology Stock Probability of Future Pink Sheet Price Finishing Over 0.0

Igene Biotechnology's future price is the expected price of Igene Biotechnology instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Igene Biotechnology performance during a given time horizon utilizing its historical volatility. Check out Igene Biotechnology Backtesting, Igene Biotechnology Valuation, Igene Biotechnology Correlation, Igene Biotechnology Hype Analysis, Igene Biotechnology Volatility, Igene Biotechnology History as well as Igene Biotechnology Performance.
  
Please specify Igene Biotechnology's target price for which you would like Igene Biotechnology odds to be computed.

Igene Biotechnology Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Igene Biotechnology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Igene Biotechnology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Igene Biotechnology generated a negative expected return over the last 90 days
Igene Biotechnology has some characteristics of a very speculative penny stock
Igene Biotechnology has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 3.96 M. Net Loss for the year was (140.75 K) with profit before overhead, payroll, taxes, and interest of 1.02 M.
Igene Biotechnology currently holds about 269.29 K in cash with (97.05 K) of positive cash flow from operations.

Igene Biotechnology Technical Analysis

Igene Biotechnology's future price can be derived by breaking down and analyzing its technical indicators over time. Igene Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Igene Biotechnology. In general, you should focus on analyzing Igene Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Igene Biotechnology Predictive Forecast Models

Igene Biotechnology's time-series forecasting models is one of many Igene Biotechnology's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Igene Biotechnology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Igene Biotechnology

Checking the ongoing alerts about Igene Biotechnology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Igene Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Igene Biotechnology generated a negative expected return over the last 90 days
Igene Biotechnology has some characteristics of a very speculative penny stock
Igene Biotechnology has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 3.96 M. Net Loss for the year was (140.75 K) with profit before overhead, payroll, taxes, and interest of 1.02 M.
Igene Biotechnology currently holds about 269.29 K in cash with (97.05 K) of positive cash flow from operations.

Other Information on Investing in Igene Pink Sheet

Igene Biotechnology financial ratios help investors to determine whether Igene Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Igene with respect to the benefits of owning Igene Biotechnology security.